Moledina Saadiq M, Kobo Ofer, Lakhani Hammad, Abhishek Abhishek, Parwani Purvi, Santos Volgman Annabelle, Bond Rachel M, Rashid Muhammad, Figtree Gemma A, Mamas Mamas A
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, United Kingdom.
Department of Cardiology, Hillel Yaffe Medical Centre, Hadera, Israel.
Int J Cardiol Heart Vasc. 2022 Oct 10;43:101135. doi: 10.1016/j.ijcha.2022.101135. eCollection 2022 Dec.
Individuals who present with STEMI without the standard cardiovascular risk factors (SMuRFs) of diabetes, hypercholesterolemia, hypertension, and smoking, coined SMuRF-less are not uncommon. Little is known about their outcomes as a cohort and how they differ by race.
METHODS & RESULTS: We identified 431,615 admissions with STEMI in the National Inpatient Sample (NIS) database 2015-2018, including patients with ≥ 1 SMuRF (n = 369,870) and those who were SMuRF-less (n = 234,745). SMuRF-less patients presented at a similar age (median age 63y vs 63y), were less likely to be female (33.6 % vs 34.6 %) and were almost twice as likely to present as a cardiac arrest (13.7 % vs 7.0 %), than those with ≥ 1 SMuRFs. SMuRF-less patients were less frequently in receipt of ICA (71.3 % vs 83.8 %) and PCI (58.0 % vs 72.2 %) compared to those with ≥ 1 SMuRF. Our race disaggregated analysis showed ethnic minority SMuRF-less patients were less likely than White patients to receive ICA and PCI, which was most apparent in Black patients with reduced odds of ICA (OR: 0.47, 95 % CI: 0.43-0.52) and PCI (OR: 0.46, 95 % CI: 0.52-0.50). Similarly, in ethnic minority subgroups within the SMuRF-less cohort, mortality and MACCE were significantly higher than in White patients. This was most profound in Black patients with in-hospital mortality (OR: 1.90, 95 % CI: 1.72-2.09) and MACCE (OR: 1.63, 95 % CI: 1.49-1.78) compared to White patients.
Ethnic Minority SMuRF-less patients were less likely than White SMuRF-less patients to receive ICA and PCI and had worse mortality outcomes.
患有ST段抬高型心肌梗死(STEMI)但没有糖尿病、高胆固醇血症、高血压和吸烟等标准心血管危险因素(SMuRFs)的个体并不罕见,这类患者被称为无SMuRFs患者。对于他们作为一个队列的结局以及种族差异知之甚少。
我们在2015 - 2018年国家住院患者样本(NIS)数据库中识别出431,615例STEMI住院病例,包括有≥1个SMuRFs的患者(n = 369,870)和无SMuRFs的患者(n = 234,745)。无SMuRFs患者的就诊年龄相似(中位年龄63岁对63岁),女性比例较低(33.6%对34.6%),且心脏骤停就诊的可能性几乎是有≥1个SMuRFs患者的两倍(13.7%对7.0%)。与有≥1个SMuRFs的患者相比,无SMuRFs患者接受冠状动脉造影(ICA)(71.3%对83.8%)和经皮冠状动脉介入治疗(PCI)(58.0%对72.2%)的频率较低。我们按种族进行的分析显示,少数族裔无SMuRFs患者接受ICA和PCI的可能性低于白人患者,这在黑人患者中最为明显,接受ICA的几率降低(比值比:0.47,95%置信区间:0.43 - 0.52),接受PCI的几率降低(比值比:0.46,95%置信区间:0.52 - 0.50)。同样,在无SMuRFs队列中的少数族裔亚组中,死亡率和主要不良心血管和脑血管事件(MACCE)显著高于白人患者。与白人患者相比,黑人患者的院内死亡率(比值比:1.90,95%置信区间:1.72 - 2.09)和MACCE(比值比:1.63,95%置信区间:1.49 - 1.78)最为显著。
少数族裔无SMuRFs患者比白人无SMuRFs患者接受ICA和PCI的可能性更低,且死亡率结局更差。